Dr. Zubair Khalid

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Section: Avian Bacteria

Avian Influenza (Bird Flu) in Humans: Zoonotic Transmission and Risk

Introduction

Avian influenza viruses (AIVs) of the genus Influenzavirus A (family Orthomyxoviridae) constitute a persistent zoonotic threat. Highly pathogenic avian influenza (HPAI) subtypes, particularly H5N1 clade 2.3.4.4b, have demonstrated an expanding host range that includes domestic poultry, wild birds, mammals, and sporadic human infections [1, 2, 32]. The question "can humans catch avian bird flu" is answered affirmatively by decades of surveillance data, though sustained human-to-human transmission remains rare [32]. This article examines the virological, ecological, and diagnostic dimensions of AIV zoonosis from a veterinary and comparative pathology perspective, emphasizing the molecular determinants that govern cross-species spillover.

Etiology and Virology

Virus Structure and Genome Organization

Influenza A viruses are enveloped, negative-sense single-stranded RNA viruses with a segmented genome comprising eight gene segments [32]. The surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) define subtype specificity; 16 HA (H1-H16) and 9 NA (N1-N9) subtypes circulate in aquatic birds, with H5 and H7 subtypes capable of evolving into HPAI phenotypes [3, 4]. The HA0 precursor protein must be cleaved by host proteases into HA1 and HA2 subunits to render the virus infectious [3]. In HPAI strains, a multibasic cleavage site (MBCS) containing multiple basic amino acids allows cleavage by ubiquitous furin-like proteases, enabling systemic infection [3, 4].

Receptor Binding and Host Range

The primary barrier to human infection is the differential distribution of sialic acid (SA) receptors. Avian influenza viruses preferentially bind α2,3-linked SA receptors, which are abundant in the avian respiratory and intestinal tracts [5, 30]. Human influenza viruses bind α2,6-linked SA receptors, predominant in the human upper respiratory epithelium [5]. Zoonotic AIVs must acquire mutations in the HA receptor-binding site (RBS) to recognize human-type receptors. Key substitutions include Q226L and G228S (H3 numbering) in H5 and H7 subtypes [5, 24]. The double mutation Q226H in H5N1 HA has been shown to enhance binding to both human-type and sialyl-Lewis X (SLeX) receptors, representing a structural adaptation toward human tropism [5, 24]. Additionally, the PB2 polymerase subunit mutations (e.g., E627K, D701N) enable efficient replication in mammalian cells by facilitating interaction with human ANP32A/B proteins [6].

Genetic Determinants of Pathogenicity

Beyond receptor specificity, multiple molecular markers contribute to mammalian adaptation. The HA MBCS is a primary determinant of virulence in poultry, but in mammals, additional residues in the polymerase complex (PB1, PA, NP) modulate replication efficiency [3, 6]. The motif 131/132-NT in H9N2 HA modulates agglutination properties and receptor specificity, influencing infectivity in mammalian models [4]. Reverse genetics studies have identified acid-stabilizing mutations in HA that enhance pH-dependent fusion, a trait associated with airborne transmission [3]. These findings underscore the multifactorial nature of zoonotic potential.

Zoonotic Transmission and Risk Factors

Routes of Human Exposure

Direct contact with infected poultry or contaminated environments is the predominant route of AIV transmission to humans [27, 28, 29]. Occupational exposure among poultry workers, live bird market vendors, and culling personnel confers the highest risk [27, 29]. The virus is shed in high concentrations in feces, respiratory secretions, and contaminated dust [7, 8]. Environmental sampling has demonstrated that AIV RNA can be detected in poultry house dust, water, and feed, providing a non-invasive surveillance tool [7]. Wastewater surveillance has emerged as a sensitive method for detecting influenza A viruses of both human and animal origin, including avian strains, in municipal systems and airport effluents [9, 10].

Host Range Expansion and Spillover Events

The 2024-2025 H5N1 clade 2.3.4.4b epizootic has been characterized by unprecedented spillover into mammalian species. Domestic cats with outdoor access in the Netherlands were found seropositive for H5 clade 2.3.4.4b and pandemic H1N1, indicating dual exposure [11]. Dairy cattle in the United States have been naturally infected with H5N1, with prolonged antibody persistence exceeding one year [33]. The detection of H5N1 in bovine milk has prompted the development of fit-for-purpose proficiency samples for RT-PCR testing in milk matrices [8]. These events highlight the plasticity of AIV host range and the potential for novel transmission pathways to humans.

Risk Factors for Human Infection

A synthesis of epidemiological data identifies several key risk factors (Table 1).

Table 1. Risk Factors for Zoonotic Avian Influenza Transmission to Humans

Risk Factor Description Evidence
Occupational exposure Poultry workers, cullers, veterinarians [27, 28, 29]
Live bird market contact High viral load in market environments [7, 35]
Consumption of raw products Unpasteurized milk, undercooked poultry [8, 33]
Environmental contamination Fomites, dust, water sources [9, 10, 7]
Co-circulation with swine Reassortment potential in pigs [12]
Immunosuppression Increased susceptibility in immunocompromised individuals [32]

The presence of swine influenza viruses in Thailand with novel reassortants underscores the role of pigs as mixing vessels for avian and mammalian influenza viruses [12]. Biosecurity assessments in commercial poultry premises in Saint Kitts revealed seroprevalence of AIV and other pathogens, emphasizing the need for rigorous biosecurity protocols [35].

Epidemiology

Global Surveillance and Outbreak Dynamics

Multimodal data approaches integrating genomic, epidemiological, and environmental data have been critical for tracking the 2024-2025 HPAI outbreak in the United States [1]. Spatiotemporal modeling using tools such as EpiDCA has enabled real-time evaluation of outbreak spread for avian influenza, African swine fever, and West Nile virus [13]. In Italy, host species contribution analysis demonstrated that wild birds and domestic poultry jointly drive the spatiotemporal dynamics of H5N1, with wild birds acting as long-distance vectors [2]. Risk prediction models for HPAI outbreaks in Kuwait have incorporated climatic, demographic, and poultry density variables to identify high-risk zones [14].

Wastewater and Environmental Surveillance

Wastewater genomic surveillance has proven effective for detecting influenza A and B viruses, revealing seasonal and off-season circulation patterns in municipal sites and international airports in Germany [10]. In California, wastewater surveillance captured both human and animal influenza A viruses, including avian lineages, during the 2024-2025 flu season [9]. Rapid field-deployable PCR platforms (e.g., GeneXpert) have been used for AIV surveillance in seabirds and environmental samples in New Zealand, providing early warning for wildlife health [15]. These approaches complement traditional flock-level sampling and reduce reliance on invasive bird handling [7].

Emerging Subtypes and Reassortment

The circulation of H9N2 viruses in Laos has led to the identification of a new clade, highlighting the ongoing evolution of low-pathogenicity AIVs with pandemic potential [26]. H9N2 viruses are endemic in poultry across Asia and the Middle East and frequently donate internal gene segments to H5N1 and H7N9 reassortants [4, 26]. Swine influenza surveillance in Thailand from 2019-2025 identified novel reassortants containing avian-origin genes, underscoring the risk of mammalian adaptation [12].

Clinical Signs and Pathology in Humans

Comparative Pathogenesis

In humans, AIV infection typically presents as an acute respiratory illness, but the pathogenesis is driven by the virus's ability to replicate in the lower respiratory tract, where α2,3-linked SA receptors are present [32]. The innate immune response to diverse influenza A viruses has been characterized using proteomics, revealing subtype-specific differences in interferon antagonism and inflammatory signaling [16]. H5N1 infection is associated with a dysregulated cytokine response (cytokine storm) that contributes to severe pathology [32].

Pathological Findings

Autopsy studies of fatal human H5N1 cases reveal diffuse alveolar damage, hemophagocytosis, and lymphoid depletion [32]. The multibasic cleavage site enables systemic replication, and viral antigen has been detected in extrapulmonary tissues including the gastrointestinal tract and brain [32]. In animal models, mouse-lethal H5N1 viruses carrying PB2-384L/443R/460M characteristics acquired in avian hosts can effectively utilize human ANP32A/B proteins, facilitating replication in mammalian cells [6].

Immune Evasion and Antibody Responses

Neutralizing antibodies targeting the HA globular head are the primary correlate of protection, but conserved epitopes such as the HA stalk and matrix protein 2 (M2) are targets for broadly protective vaccines [17, 18]. A VSV-vectored vaccine targeting H5N1 HA and M2 induced robust neutralizing and ADCC antibody responses in mice [17]. Nanobodies targeting a conserved lateral patch on HA1 have shown neutralization breadth against multiple H7 subtypes [18]. Multi-epitope HA vaccines have demonstrated cross-protective immunity against H5N8 and H9N2 in animal models [31].

Diagnostics

Molecular Detection Methods

Reverse transcription polymerase chain reaction (RT-PCR) targeting the matrix (M) gene is the gold standard for AIV detection [19, 20]. Subtype-specific assays for H5, H7, and H9 are widely used. Comparative analysis of laboratory-based and portable qPCR platforms (CFX, MIC, Biomeme Franklin) for AIV and African swine fever detection showed comparable sensitivity and specificity, supporting field deployment [19]. The lower limit of detection of commercial respiratory virus RT-PCR panels for bovine influenza A(H5N1) has been evaluated, with implications for diagnostic accuracy in milk and respiratory specimens [20].

Environmental and Non-Invasive Sampling

Environmental samples (dust, feces, water) offer a sensitive alternative to individual bird sampling for surveillance of H9N2 in vaccinated turkey flocks [7]. Proficiency samples for interlaboratory evaluation of RT-PCR detection of HPAI H5N1 in milk have been developed to standardize testing across laboratories [8]. Wastewater genomic surveillance provides population-level data without direct animal contact [9, 10].

Table 2. Diagnostic Approaches for Avian Influenza Virus Detection

Method Sample Type Target Application
RT-PCR (M gene) Swabs, tissues, milk Matrix gene Universal screening
Subtype-specific RT-PCR Swabs, environmental HA/NA genes Subtype identification
Portable qPCR Field samples M gene Point-of-care surveillance
Sequencing (Sanger/NGS) Isolates, wastewater Whole genome Phylogenetics, mutation tracking
Serology (ELISA, HI) Serum Antibodies Exposure history, vaccine response

Genomic Surveillance and Bioinformatics

High-throughput sequencing of AIV genomes from clinical and environmental samples enables real-time tracking of mutations associated with mammalian adaptation [1, 9]. Wastewater genomic surveillance can detect minority variants and reassortment events [10]. Computational models integrating genomic, ecological, and demographic data are used to predict pandemic potential [16, 34]. The development of a high-resolution digital twin of interacting livestock, wild birds, and human ecosystems in the United States allows simulation of multihost epidemic spread [34].

Treatment and Antiviral Resistance

Antiviral Compounds

Neuraminidase inhibitors (oseltamivir, zanamivir) are the primary antiviral agents for influenza, including avian strains [21, 25]. In vitro efficacy of anti-influenza compounds against clinical isolates with high growth capability has been assessed, with some isolates showing reduced susceptibility [25]. Antiviral resistance in influenza poses clinical and public health challenges, with resistance mutations (e.g., H275Y in N1) emerging under drug pressure [21].

Vaccination Strategies in Animals

Vaccination of poultry is a key control measure, but vaccine efficacy depends on antigenic match with circulating strains. A trimeric HA vaccine provided chickens complete protection against lethal H5 subtype clade 2.3.4.4b challenge [22]. A reverse genetics-based NS1-truncated live attenuated vaccine conferred broad heterologous protection against swine influenza viruses, demonstrating the potential for cross-protective vaccines [23]. Multi-epitope HA vaccines have shown cross-protective immunity against H5N8 and H9N2 [31]. However, vaccination can mask infection and complicate surveillance, necessitating DIVA (differentiating infected from vaccinated animals) strategies.

Control and Prevention

Biosecurity Measures

Strict biosecurity is the cornerstone of AIV prevention in poultry. Measures include limiting contact between domestic poultry and wild birds, disinfection of equipment and vehicles, and controlling human access to flocks [35]. Biosecurity assessments in Saint Kitts commercial poultry premises identified gaps in hygiene protocols and recommended improvements [35]. In the Republic of Korea, preventive measures against human avian influenza infection include personal protective equipment (PPE) for high-risk workers, culling protocols, and public health education [27, 28, 29].

One Health Surveillance

Integrated surveillance across human, animal, and environmental sectors is essential for early detection and response. The EpiDCA framework enables spatiotemporal evaluation of disease clusters [13]. Risk prediction models for HPAI outbreaks in Kuwait incorporate climatic and demographic variables [14]. The digital twin model for multihost epidemic spread in the United States allows scenario testing for intervention strategies [34].

Public Health Preparedness

While this article focuses on veterinary aspects, the zoonotic risk necessitates collaboration between veterinary and public health authorities. Surveillance of influenza A viruses in swine and poultry, combined with genomic characterization, informs pandemic risk assessment [12, 26]. The detection of antibodies to H5N1 in naturally infected cattle for over a year highlights the need for long-term monitoring of mammalian hosts [33].

graph TD
    A[Wild Aquatic Birds], >|Fecal-oral, respiratory| B[Domestic Poultry]
    B, >|Direct contact, fomites| C[Humans]
    A, >|Environmental contamination| D[Water, Dust, Fomites]
    D, > C
    B, >|Milk, meat| E[Livestock (Cattle, Swine)]
    E, >|Occupational exposure| C
    C, >|Limited human-to-human| C
    A, >|Spillover| F[Mammals (Cats, Foxes)]
    F, >|Close contact| C
    style A fill:#f9f,stroke:#333,stroke-width:2px
    style B fill:#bbf,stroke:#333,stroke-width:2px
    style C fill:#f96,stroke:#333,stroke-width:2px
    style D fill:#ff9,stroke:#333,stroke-width:2px
    style E fill:#9f9,stroke:#333,stroke-width:2px
    style F fill:#9cf,stroke:#333,stroke-width:2px

Figure 1. Transmission pathways of avian influenza viruses from reservoir hosts to humans. Wild aquatic birds are the natural reservoir. Spillover to domestic poultry and mammals creates multiple routes of human exposure.

Conclusion

Avian influenza viruses remain a significant zoonotic threat due to their genetic plasticity, expanding host range, and ability to acquire mutations that facilitate human infection. The question "can humans catch avian bird flu" is unequivocally answered by documented cases, but the risk of sustained human-to-human transmission remains low in the absence of further adaptation. Veterinary surveillance, molecular diagnostics, and biosecurity are the primary defenses against spillover. Continued integration of genomic, ecological, and epidemiological data within a One Health framework is essential for pandemic preparedness.

References

[1] Sopko J, Han AR, Powers J et al. Multimodal Data Approaches for Examining the 2024-2025 Highly Pathogenic Avian Influenza Outbreak in the United States: Descriptive Study. JMIR Public Health Surveill. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330167/

[2] Savegnago E, Cavicchio L, Dianati M et al. Host Species Contribution to the Spatiotemporal Dynamics of the 2024-2025 H5N1 Epidemic in Italy. Influenza Other Respir Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42299833/

[3] Rimaux S, Oliva MF, Mestdagh C et al. New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations. Microbiol Spectr. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42294944/

[4] Chen X, Dong J, Zhao C et al. Dominant HA motif 131/132-NT shapes the phenotype of avian H9N2 influenza virus by modulating agglutination property, receptor specificity and infectivity in animals. Virol Sin. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42288138/

[5] Jin X, Han P, Wang Y et al. Hemagglutinin double-mutation enhances binding of human-infecting avian influenza virus clade 2.3.4.4b H5Ny to human and SLe(X) receptors. EMBO Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42303811/

[6] Lin W, Deng G, Xing X et al. The mouse-lethal H5N1 influenza virus

[7] Kalvelage L, Casteel M, Hartmann M et al. Environmental samples, a sensitive and practical alternative to individual bird sampling in the surveillance of H9N2 vaccinated turkey flocks. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42262844/

[8] Smith EL, Jin Y, Miller MR et al. Development of Fit-for-Purpose, High Quality Proficiency Samples for Interlaboratory Evaluation of RT-PCR Detection of HPAI H5N1 in Milk. Food Environ Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42258002/

[9] Wang AL, Lamtyugina A, Jiang M et al. Genomic wastewater surveillance of human and animal influenza A viruses in California during the 2024-2025 flu season. medRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42326814/

[10] Moore CJ, Zachmann K, Lackner S et al. Wastewater genomic surveillance of influenza A and B reveals seasonal and off-season circulation differences between municipal sites and an international airport, Germany, 2024. Water Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42320401/

[11] Duijvestijn MBHM, Broens EM, Schuurman NNMPNMP et al. EXPRESS: Highly pathogenic avian influenza H5 clade 2.3.4.4 and human new pandemic H1N1 virus exposure in domestic cats with outdoor access in the Netherlands in 2024. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42265865/

[12] Chaiyawong S, Phyu HW, Nasamran C et al. Genetic Characterization of Swine Influenza Viruses in Thailand in 2019-2025 Reveals Novel Reassortants. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253333/

[13] Boudoua B, Roche M, Teisseire M et al. Spatio-temporal evaluation of EpiDCA: Case studies on avian influenza, African swine fever, and West Nile virus disease. Spat Spatiotemporal Epidemiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42285614/

[14] Alshatti M, Al-Hemoud A, Othman A et al. A risk prediction model for HPAI outbreaks in Kuwait. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42290772/

[15] Heremia L, Langsbury H, Treece J et al. Rapid GeneXpert surveillance of influenza A virus in seabirds and the environment provides early warning for wildlife health in Aotearoa New Zealand. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42322875/

[16] Gerodez A, Dos Santos M, Attia M et al. Toward Predicting Pandemic Potential: A Comparative Analysis of Virus-Host Interactions Between Diverse Influenza A Viruses and the Human Innate Immune System. Proteomics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42319249/

[17] Ao Z, Vendramelli R, Buyu M et al. A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42300735/

[18] Xu S, Zhang Q, Xie X et al. A neutralizing nanobody targeting a conserved lateral patch on HA1 confers protection against multiple H7 avian influenza viruses. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42274212/

[19] Auer A, Settypalli TBK, Rozstalnyy A et al. Comparative analysis of laboratory-based and portable qPCR platforms: CFX, MIC, and Biomeme Franklin for African swine fever and avian influenza detection. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42321793/

[20] Higerd-Rusli GP, Hoffman SA, Karan A et al. Lower limit of detection of commercial respiratory virus reverse transcriptase-polymerase chain reaction panels for bovine influenza A(H5N1). Am J Clin Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308142/

[21] Ngiam JN, Koh MCY, Hayden FG. Antiviral Resistance in Influenza: Clinical and Public Health Implications. Influenza Other Respir Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42306964/

[22] Chen T, Huang Q, Chen X et al. Trimeric hemagglutinin vaccine provides chickens complete protection against lethal H5 subtype avian influenza virus from clade 2.3.4.4b. Emerg Microbes Infect. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42269026/

[23] Xiang F, Xu Y, Liu C et al. A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42303005/